1. Home
  2. RDHL vs ATPC Comparison

RDHL vs ATPC Comparison

Compare RDHL & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • ATPC
  • Stock Information
  • Founded
  • RDHL 2009
  • ATPC 2016
  • Country
  • RDHL Israel
  • ATPC Malaysia
  • Employees
  • RDHL N/A
  • ATPC N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • ATPC Medical/Nursing Services
  • Sector
  • RDHL Health Care
  • ATPC Health Care
  • Exchange
  • RDHL Nasdaq
  • ATPC Nasdaq
  • Market Cap
  • RDHL 4.3M
  • ATPC 68.0M
  • IPO Year
  • RDHL N/A
  • ATPC N/A
  • Fundamental
  • Price
  • RDHL $2.15
  • ATPC $1.47
  • Analyst Decision
  • RDHL
  • ATPC
  • Analyst Count
  • RDHL 0
  • ATPC 0
  • Target Price
  • RDHL N/A
  • ATPC N/A
  • AVG Volume (30 Days)
  • RDHL 18.2K
  • ATPC 55.8K
  • Earning Date
  • RDHL 08-28-2025
  • ATPC 08-13-2025
  • Dividend Yield
  • RDHL N/A
  • ATPC N/A
  • EPS Growth
  • RDHL N/A
  • ATPC N/A
  • EPS
  • RDHL N/A
  • ATPC N/A
  • Revenue
  • RDHL $8,042,999.00
  • ATPC $1,293,141.00
  • Revenue This Year
  • RDHL $381.91
  • ATPC N/A
  • Revenue Next Year
  • RDHL N/A
  • ATPC N/A
  • P/E Ratio
  • RDHL N/A
  • ATPC N/A
  • Revenue Growth
  • RDHL 23.17
  • ATPC N/A
  • 52 Week Low
  • RDHL $1.71
  • ATPC $0.90
  • 52 Week High
  • RDHL $20.28
  • ATPC $6.80
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 64.10
  • ATPC 45.37
  • Support Level
  • RDHL $2.00
  • ATPC $1.37
  • Resistance Level
  • RDHL $2.08
  • ATPC $1.47
  • Average True Range (ATR)
  • RDHL 0.09
  • ATPC 0.09
  • MACD
  • RDHL 0.03
  • ATPC 0.02
  • Stochastic Oscillator
  • RDHL 100.00
  • ATPC 47.48

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

Share on Social Networks: